(Q33889654)

29 July 2017

title

Leptin signaling and apoptotic effects in human prostate cancer cell lines (English)

1 reference

29 July 2017

0 references

1 reference

Sigal Samuel-Mendelsohn

1

1 reference

29 July 2017

Michal Inbar

2

1 reference

29 July 2017

Esther Weiss-Messer

3

1 reference

29 July 2017

Leonora Niv-Spector

4

1 reference

29 July 2017

Arieh Gertler

5

1 reference

29 July 2017

Ronnie J Barkey

6

1 reference

29 July 2017

publication date

6 December 2010

1 reference

29 July 2017

1 reference

29 July 2017

volume

71

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

929-945

1 reference

Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Unraveling the complexities of androgen receptor signaling in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Prostate cancer: Re-focusing on androgen receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Obesity and prostate cancer: epidemiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin signaling in breast cancer: An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Molecular and neural mediators of leptin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Intracellular signalling pathways activated by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Transactivation of erbB2 by short and long isoforms of leptin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin augments proliferation of breast cancer cells via transactivation of HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Androgen-dependent regulation of Her-2/neu in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin induces cell migration and the expression of growth factors in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Differential effects of leptin on cancer in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Prostate cancer cell proliferation is influenced by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Regulation of growth hormone receptors in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin induces apoptosis via ERK/cPLA2/cytochrome c pathway in human bone marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Apoptosis generates stable fragments of human type I keratins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Keratin 8/18 breakdown and reorganization during apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Exposure of glia to pro-oxidant agents revealed selective Stat1 activation by H2O2 and Jak2-independent antioxidant features of the Jak2 inhibitor AG490

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Dihydrotestosterone enhances transforming growth factor-beta-induced apoptosis in hormone-sensitive prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin induces angiopoietin-2 expression in adipose tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin-induced adipose apoptosis: Implications for body weight regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

c-Jun NH(2)-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin analog antagonizes leptin effects on food intake and body weight but mimics leptin-induced vagal afferent activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Androgen receptor and growth factor signaling cross-talk in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

The complex role of AR signaling after cytotoxic insult: implications for cell-cycle-based chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Androgen and its receptor promote Bax-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

Molecular biology of the androgen receptor: from molecular understanding to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21309

21 January 2018

Identifiers

DOI

10.1002/PROS.21309

1 reference

29 July 2017

1 reference